Gough Au

Post Doctoral Scientist

Newcastle Innovation

City
Newcastle, Australia
Discipline
Biological Sciences
Interests
Oncolytic Virotherapy
More... Less...

  • 7 Followers

Stats

About

Dr Gough Au is an early career researcher and currently appointed as a NHMRC Industry Research fellow (2007-2011). He is carrying out his four-year term in conjunction with The University of Newcastle and industry partner Viralytics Ltd. Gough's main research interest is in the development of naturally occurring viruses with selective anti-cancer properties, for the treatment of melanoma, multiple myeloma and malignant glioma.
More... Less...

Publications

  • Novel marker for recombination in the 3'-untranslated region of members of the species Human enterovirus A.

    Kok C, Au G

    Archives of virology (2012)

    • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.
  • Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18

    Au G, Beagley L, Haley E, Barry R, Shafren D

    Virology Journal (2011)

    • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.
  • Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex.

    Tooney P, Au G, Chahl L

    Neuroscience letters (2000)

    • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.
  • Tachykinin NK1 and NK3 receptors in the prefrontal cortex of the human brain.

    Tooney P, Au G, Chahl L

    Clinical and experimental pharmacology & physiology (2000)

    • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.
  • Systemic therapy of malignant human melanoma tumors by a common cold-producing enterovirus, coxsackievirus a21.

    Shafren D, Au G, Nguyen T, Newcombe N, Haley E, Beagley L et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research (2004)

    • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.
  • Potent oncolytic activity of human enteroviruses against human prostate cancer.

    Berry L, Au G, Barry R, Shafren D

    The Prostate (2008)

    • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.
  • Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer.

    Haley E, Au G, Carlton B, Barry R, Shafren D

    Journal of molecular medicine (Berlin, Germany) (2009)

    • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.
  • Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma.

    Au G, Lincz L, Enno A, Shafren D

    British journal of haematology (2007)

    • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.
  • Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21.

    Au G, Lindberg a, Barry R, Shafren D

    International journal of oncology (2005)

    • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Professional experience

Post Doctoral Scientist

Newcastle Innovation

May 2011 - Present

Post Doctoral Scientist

The University of Newcastle, Australia

May 2007 - May 2011 (4 years)

Research Director

The University of Newcastle Research Associates (TUNRA) now Newcastle Innovation

August 2004 - May 2007 (2 years 9 months)

Education history

The University of Newcastle, Australia

Doctor of Philosophy [Immunology & Microbiology]

February 2001 - September 2005 (4 years 7 months)

The University of Newcastle, Australia

Bachelor of Biomedical Science [Honours]

March 2000 - December 2000 (9 months)

The University of Newcastle, Australia

Bachelor of Biomedical Science

March 1997 - December 1999 (2 years 9 months)